CSTD for non-IV routes

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

5 posts / 0 new
Log in or register to post comments
Last post
Tue, 01/12/2021 - 14:20
#1
Jeff Hurren
Jeff Hurren's picture
Offline
Last seen: 1 week 5 days ago
Joined: 07/05/2019 - 08:29
CSTD for non-IV routes

We are re-evaluating our processes around Closed System Drug-Transfer Devices (CSTD). I am curious to hear of other institutional approaches to non-IV routes:

Do you use the same CSTD system across your enterprise for consistency, or a different one to distinguish?

In particular I am thinking of intravesicular, intramuscular, and/or Subcutaneous routes.

Top